• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Tina Y. Poussaint, MD


  • Dombi E, Ardern-Holmes SL, Babovic-Vuksanovic D, Barker FG, Connor S, Evans DG, Fisher MJ, Goutagny S, Harris GJ, Jaramillo D, Karajannis MA, Korf BR, Mautner V, Plotkin SR, Poussaint TY, Robertson K, Shih CS, Widemann BC, .Recommendations for imaging tumor response in neurofibromatosis clinical trials.Neurology. 2013 Nov 19;81(21 Suppl 1):S33-40.
  • Zukotynski KA, Fahey FH, Vajapeyam S, Ng SS, Kocak M, Gururangan S, Kun LE, Poussaint TY.Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.J Nucl Med. 2013 Aug;54(8):1237-43.
  • Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW.Challenges With Defining Response to Antitumor Agents in Pediatric Neuro-Oncology: A Report From the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.Pediatr Blood Cancer. 2013 Apr 26.
  • Gururangan S, Fangusaro J, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Gajjar A, Goldman S, Friedman HS, Packer RJ, Boyett JM, Kun LE, McLendon R.Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study.Neuro Oncology. 2012 Nov;14(11):1404-12.
  • Prabhu SP, Ng S, Vajapeyam S, Kieran MW, Pollack IF, Geyer R, Haas-Kogan D, Boyett JM, Kun L, Poussaint TY.DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium.Child's Nervous System : Ch Ns : Official Journal Of The International Society For Pediatric Neurosurgery. 2011 Jan;27(1):11-8.
  • Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY.Variability in PET quantitation within a multicenter consortium.Med Phys. 2010 Jul;37(7):3660-6.
  • Saad A, Folkerth R, Poussaint T, Smith E, Ligon K.Meningioangiomatosis associated with meningioma: a case report.Acta Cytol.;53(1):93-7.
  • Kieran MW,Supko JG,Wallace D,Fruscio R,Poussaint TY,Phillips P,Pollack I,Packer R,Boyett JM,Blaney S,Banerjee A,Geyer R,Friedman H,Goldman S,Kun LE,Macdonald T.Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.Pediatr Blood Cancer. 2009 Feb;52(2):169-76.
  • Williams G, Fahey FH, Treves ST, Kocak M, Pollack IF, Boyett JM, Kun LE, Poussaint TY.Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC).Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1651-8.
  • Mulkern RV,Forbes P,Dewey K,Osganian S,Clark M,Wong S,Ramamurthy U,Kun L,Poussaint TY.Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium.Acad Radiol. 2008 Sep;15(9):1099-110.
  • Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE.Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.Neuro-oncol. 2008 Jun;10(3):341-7.
  • Gururangan S, Turner CD, Stewart CF, O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R, Pollack IF, Blaney SM, Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LE.Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study.Clin Cancer Res. 2008 Feb 15;14(4):1124-30.
  • MacDonald TJ, Stewart CF, Kocak M, Goldman S, Ellenbogen RG, Phillips P, Lafond D, Poussaint TY, Kieran MW, Boyett JM, Kun LE.Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.J Clin Oncol. 2008 Feb 20;26(6):919-24.
  • Broniscer A, Gururangan S, MacDonald TJ, Goldman S, Packer RJ, Stewart CF, Wallace D, Danks MK, Friedman HS, Poussaint TY, Kun LE, Boyett JM, Gajjar A.Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6712-8.
  • Liu AK, Marcus KJ, Fischl B, Grant PE, Young Poussaint T, Rivkin MJ, Davis P, Tarbell NJ, Yock TI.Changes in cerebral cortex of children treated for medulloblastoma.Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):992-8.
  • Poussaint TY, Phillips PC, Vajapeyam S, Fahey FH, Robertson RL, Osganian S, Ramamurthy U, Mulkern RV, Treves ST, Boyett JM, Kun LE.The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress.AJNR Am J Neuroradiol. 2007 Apr;28(4):603-7.
  • Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM.Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.Neuro-oncol. 2007 Apr;9(2):145-60.
  • Marcus KJ, Astrakas LG, Zurakowski D, Zarifi MK, Mintzopoulos D, Poussaint TY, Anthony DC, De Girolami U, Black PM, Tarbell NJ, Tzika AA.Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.Int J Oncol. 2007 Mar;30(3):651-7.
  • Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW.Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.J Neurooncol. 2007 Mar;82(1):95-101.
  • Fouladi M, Blaney SM, Poussaint TY, Freeman BB, McLendon R, Fuller C, Adesina AM, Hancock ML, Danks MK, Stewart C, Boyett JM, Gajjar A.Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.Cancer. 2006 Nov 1;107(9):2291-7.
  • Anselm IM, Alkuraya FS, Salomons GS, Jakobs C, Fulton AB, Mazumdar M, Rivkin M, Frye R, Poussaint TY, Marsden D.X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype.J Inherit Metab Dis. 2006 Feb;29(1):214-9.
  • Poussaint TY, Rodriguez D.Advanced neuroimaging of pediatric brain tumors: MR diffusion, MR perfusion, and MR spectroscopy.Neuroimaging Clin N Am. 2006 Feb;16(1):169-92, ix. Review.
  • Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, Bomgaars L, Blaney SM, Kun LE, Boyett JM.Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).Clin Cancer Res. 2006 Mar 1;12(5):1540-6.
  • Baser ME, Poussaint TY.Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.J Med Genet. 2006 Mar;43(3):285-7.
  • Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM.Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.Cancer. 2004 Mar 15;100(6):1246-56.
  • Caruso PA, Poussaint TY, Tzika AA, Zurakowski D, Astrakas LG, Elias ER, Bay C, Irons MB.MRI and (1)H MRS findings in Smith-Lemli-Opitz syndrome.Neuroradiology. 2004 Jan;46(1):3-14.
  • Jaramillo D, Poussaint TY, Grottkau BE.Scoliosis: evidence-based diagnostic evaluation.Neuroimaging Clin N Am. 2003 May;13(2):335-41, xii.
  • Heath JA, Turner CD, Poussaint TY, Scott RM, Goumnerova L, Kieran MW.Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.Pediatr Hematol Oncol. 2003 Oct-Nov;20(7):497-504.
  • Poussaint TY, Jaramillo D, Chang Y, Korf B.Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas.AJR Am J Roentgenol. 2003 Feb;180(2):419-23.
  • Zarifi MK, Astrakas LG, Poussaint TY, Plessis Ad A, Zurakowski D, Tzika AA.Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia.Radiology. 2002 Dec;225(3):859-70.
  • Poussaint TY, Moeller KK.Imaging of pediatric head trauma.Neuroimaging Clin N Am. 2002 May;12(2):271-94, ix.
  • Tzika AA, Zarifi MK, Goumnerova L, Astrakas LG, Zurakowski D, Young-Poussaint T, Anthony DC, Scott RM, Black PM.Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.AJNR Am J Neuroradiol. 2002 Feb;23(2):322-33.
  • Faerber EN, Poussaint TY.Magnetic resonance of metabolic and degenerative diseases in children.Top Magn Reson Imaging. 2002 Feb;13(1):3-21.
  • O'Tuama LA, Poussaint TY.Thallium-201 single-photon emission CT in recurrent squamous cell carcinoma of the head and neck.AJNR Am J Neuroradiol. 2002 Jan;23(1):174-5.
  • Poussaint TY.Magnetic resonance imaging (MRI) is one of the most important imaging modalities in pediatric neuroradiology.Top Magn Reson Imaging. 2001 Dec;12(6):359.
  • Poussaint TY.Magnetic resonance imaging of pediatric brain tumors: state of the art.Top Magn Reson Imaging. 2001 Dec;12(6):411-33.
  • Young Poussaint T, Yousuf N, Barnes PD, Anthony DC, Zurakowski D, Scott RM, Tarbell NJ.Cervicomedullary astrocytomas of childhood: clinical and imaging follow-up.Pediatr Radiol. 1999 Sep;29(9):662-8.
  • O'Tuama LA, Poussaint TY, Anthony DC, Treves ST.Childhood brain tumor: neuroimaging correlated with disease outcome.Pediatr Neurol. 1998 Oct;19(4):259-62.
  • Poussaint TY, Kowal JR, Barnes PD, Zurakowski D, Anthony DC, Goumnerova L, Tarbell NJ.Tectal tumors of childhood: clinical and imaging follow-up.AJNR Am J Neuroradiol. 1998 May;19(5):977-83.
  • Medina LS, Zurakowski D, Strife KR, Robertson RL, Poussaint TY, Barnes PD.Efficacy of fast screening MR in children and adolescents with suspected intracranial tumors.AJNR Am J Neuroradiol. 1998 Mar;19(3):529-34.
  • Poussaint TY, Barnes PD, Nichols K, Anthony DC, Cohen L, Tarbell NJ, Goumnerova L.Diencephalic syndrome: clinical features and imaging findings.AJNR Am J Neuroradiol. 1997 Sep;18(8):1499-505.
  • Robertson RL, Burrows PE, Barnes PD, Robson CD, Poussaint TY, Scott RM.Angiographic changes after pial synangiosis in childhood moyamoya disease.AJNR Am J Neuroradiol. 1997 May;18(5):837-45.
  • Poussaint TY, Barnes PD, Anthony DC, Spack N, Scott RM, Tarbell NJ.Hemorrhagic pituitary adenomas of adolescence.AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1907-12.
  • Levy HL, Lobbregt D, Barnes PD, Poussaint TY.Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring.J Pediatr. 1996 Jun;128(6):770-5.
  • Poussaint TY, Siffert J, Barnes PD, Pomeroy SL, Goumnerova LC, Anthony DC, Sallan SE, Tarbell NJ.Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up.AJNR Am J Neuroradiol. 1995 Apr;16(4):693-9.
  • Appignani BA, Jaramillo D, Barnes PD, Poussaint TY.Dysraphic myelodysplasias associated with urogenital and anorectal anomalies: prevalence and types seen with MR imaging.AJR Am J Roentgenol. 1994 Nov;163(5):1199-203.
  • Strand RD, Barnes PD, Poussaint TY, Estroff JA, Burrows PE.Cystic retrocerebellar malformations: unification of the Dandy-Walker complex and the Blake's pouch cyst.Pediatr Radiol. 1993;23(4):258-60.